Key result
Persistent pulmonary hypertension affects up to ~50% after ASD closure, worsening major cardiovascular events and mortality risk.
Why the study?
Persistent pulmonary hypertension after atrial septal defect closure presents ongoing clinical challenges and is associated with a poorer prognosis.
Answers are grounded in this paper and cite their sources.
Persistent pulmonary hypertension occurs in 5% to 50% of patients after atrial septal defect closure—predicted by older age, ventricular dysfunction, atrial fibrillation, and poor functional class—necessitating careful pre-procedural risk stratification, potential 'treat-and-repair' strategies, and lifelong structured follow-up.
Atrial septal defect (ASD) is one of the most common congenital heart diseases (CHD), which, if left untreated, may cause pulmonary hypertension (PH) and subsequently worsen clinical outcomes. Defect closure is one of the management strategies for ASD; however, persistent post-closure PH produces challenges with a poorer prognosis. Pulmonary hypertension in ASD is multifactorial, involving pulmonary vascular remodelling from a chronic left-to-right shunt. Numerous studies have consistently identified several key predictors for persistent PH, including advanced age at closure, right and left ventricular dysfunction, atrial fibrillation, poor NYHA functional class (III-IV), and comorbidities such as diabetes mellitus and systemic hypertension. The presence of post-closure PH significantly increases the risk of major adverse cardiovascular and cerebrovascular events, heart failure, and mortality. Consequently, modern management approaches are shifting towards more personalized strategies, such as a "treat-and-repair" approach for high-risk patients and structured lifelong evaluation.
No takes yet. Share an insight, caveat, or question.
Gultom et al. (2026) conducted a review in Pulmonary hypertension after atrial septal defect (ASD) closure. Atrial septal defect closure was evaluated on Persistent pulmonary hypertension after ASD closure. Persistent pulmonary hypertension occurs in 5% to 50% of patients following atrial septal defect closure and significantly increases the risk of major adverse cardiovascular events and mortality.
Synapse has enriched 10 related papers. Consider them for comparative context: